English French German
 

Franchise Global Health Inc. Announces Timing of Release of First Quarter Results and Conference Call

 

Global Seed to Sale Medical Cannabis Leader

Award winning genetics + world class cultivation + state of the art processing + established European distribution platform

FGH.V

1st

Medical Cannabis Import and Distribution License in Germany

1200

German Pharmacies Network

$1.25 Billion

Estimated German Medical Cannabis Market by 2025 [1]

$4 Billion

Estimated European Medical Cannabis Market by 2025 [2]

ABOUT US

Franchise Global Health is a fully integrated medical cannabis company focused on building industry-leading, European-focused medical cannabis operations with an expertise in genetics, cultivation, and pharma distribution.

Franchise has an early mover advantage in the European market after receiving the first import and distribution license in Germany and will leverage this expertise to achieve profitable growth and build sustainable, long-term shareholder value.


 

Our People

A Message from Our CEO, Clifford Starke

OUR BUSINESS

GENETICS Franchise’s portfolio includes 286 highly sought out strains. Europe’s 1st legal and registered seed bank.
genetics
Cultivation 500,000 sq. ft reserved cultivation capacity at an EU GMP certified facility in Ontario, Canada that has delivered to Germany in addition to numerous low-cost, long term strategic cultivation assets in the pipeline.
genetics
Processing State of the art 30,000 sq. ft EU-GMP facility located in Ontario, Canada and a 90,000 sq. ft EU-GMP facility in Germany.
genetics
Distribution Franchise Global Health’s subsidiaries are well established pharmaceutical wholesalers & distributors with a strong network of over 1,200 German pharmacies for cannabis sales with pharma distribution relationships across 18 countries.
distribution
Strategic Investments Management has expertise and a track record of making accretive acquisitions in the highly competitive global cannabis market.
genetics

GLOBAL FOOTPRINT

WHY INVEST ?

 
 

Top 5 Reasons to Invest in
FRANCHISE GLOBAL HEALTH

    1. World-renowned team with a proven track record
    2. First-mover advantage in Germany
    3. Significant revenues with strong projected growth
    4. Award-winning proprietary genetics
    5. Established German footprint with 1,200 German pharmacies in place with additional pharma distribution relationships across 18 countries

SIGN UP TO GET OUR PRESENTATION

Form by ChronoForms - ChronoEngine.com

1. RBC Capital Markets: Miehm, D., & Oliphant , M. (2020). Extractor Industry Primer: Providing the Foundation for Cannabis Rec 2.0. RBC Dominion Securities Inc.

2. Brightfield Group, Hanway Associates. (2020). Succeeding in European Cannabis Fall 2020 Report. Chicago: Brightfield Group.